DrugPatentWatch Database Preview
Sarepta Theraps Inc Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for SAREPTA THERAPS INC, and what generic alternatives to SAREPTA THERAPS INC drugs are available?
SAREPTA THERAPS INC has two approved drugs.
There are sixteen US patents protecting SAREPTA THERAPS INC drugs.
There are one hundred and seventy-eight patent family members on SAREPTA THERAPS INC drugs in twenty-four countries.
Summary for Sarepta Theraps Inc
| International Patents: | 178 |
| US Patents: | 16 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Sarepta Theraps Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION;INTRAVENOUS | 206488-001 | Sep 19, 2016 | RX | Yes | Yes | RE47751 | Start Trial | Start Trial | ||||
| Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION;INTRAVENOUS | 206488-002 | Sep 19, 2016 | RX | Yes | Yes | 9,416,361 | Start Trial | Y | Start Trial | |||
| Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION;INTRAVENOUS | 206488-002 | Sep 19, 2016 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION;INTRAVENOUS | 206488-002 | Sep 19, 2016 | RX | Yes | Yes | 10,533,174 | Start Trial | Y | Start Trial | |||
| Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION;INTRAVENOUS | 206488-002 | Sep 19, 2016 | RX | Yes | Yes | 9,243,245 | Start Trial | Y | Start Trial | |||
| Sarepta Theraps Inc | VYONDYS 53 | golodirsen | SOLUTION;INTRAVENOUS | 211970-001 | Dec 12, 2019 | RX | Yes | Yes | 10,266,827 | Start Trial | Start Trial | ||||
| Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION;INTRAVENOUS | 206488-002 | Sep 19, 2016 | RX | Yes | Yes | 8,486,907 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Sarepta Theraps Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2004276334 | Start Trial |
| Hungary | E035799 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2010054267 | Start Trial |
| Japan | 2016033140 | Start Trial |
| Denmark | 1766010 | Start Trial |
| Cyprus | 1120486 | Start Trial |
| European Patent Office | 2735568 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
